Additionally, some research explored potential biomarkers, such as the Cerebellar Cognitive Affective Syndrome Scale (CCAS‐S) and neurofilament light chain, to assess cognitive impairments and monitor disease progression.14, 15, 17. The gene discussed is NEFL; the disease is Cognitive impairment.